Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. — Investor Relations & Filings

Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 341170

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Regulatory Filings
2026-04-30 Korean
[기재정정]주요사항보고서(유상증자결정)
Regulatory Filings
2026-04-30 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a ‘주주총회 소집공고’ (notice of convocation of the 12th extraordinary general meeting of shareholders) containing the meeting date, agenda items (director election), candidate biographies, and supporting information sent to shareholders to solicit votes. This fits the Proxy Solicitation & Information Statement category.
2026-04-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the formal results of a regular Annual General Meeting held on 2026-03-31. It lists each agenda item, approval status, voting percentages, and resolutions adopted by shareholders. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory disclosure concerning the appointment and dismissal (or mid-term resignation) of outside directors (“사외이사의 선임ㆍ해임 또는 중도퇴임”). It details the change date, numbers before and after, and profiles of incoming and outgoing board members. This clearly falls under announcements of changes in the company's board of directors or senior management, which matches the Board/Management Information category.
2026-03-31 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a corporate announcement in Korean detailing the change of the company’s 대표이사 (CEO/representative director), including before/after names, dates of change and board resolution, attendance information, and background of the new CEO. This fits exactly the definition of "Board/Management Information" (announcement of senior management changes).
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.